对于同步TNBC和HER2+乳腺癌的KEYNOTE522和HER2导向疗法的病理完整反应

Nicholas Mai1, Jie-Fu Chen2, Satshil Rana2

  • 1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

PubMed
概括

本案例研究详细介绍了一个罕见的案例,一个患者患有两种不同的乳腺癌,成功地用联合化疗免疫疗法治疗. 混合方法导致了完全的病理反应,在治疗异质三阴性和HER2+乳腺癌方面表现出有效性.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
865